Global Equine Pharmaceuticals and Supplements Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
The Equine Pharmaceuticals and Supplements market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Equine Pharmaceuticals and Supplements size is estimated to be xx million in 2021 from USD 1208.1 million in 2020, with a change of XX% between 2020 and 2021. The global Equine Pharmaceuticals and Supplements market size is expected to grow at a CAGR of 4.3% for the next five years.
Market segmentation
Equine Pharmaceuticals and Supplements market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Pharmaceuticals
Supplements
Market segment by Application can be divided into
Thoroughbred Horse
Other Types of Horses
The key market players for global Equine Pharmaceuticals and Supplements market are listed below:
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Equine Pharmaceuticals and Supplements product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Equine Pharmaceuticals and Supplements, with price, sales, revenue and global market share of Equine Pharmaceuticals and Supplements in 2018 and 2019.
Chapter 3, the Equine Pharmaceuticals and Supplements competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Equine Pharmaceuticals and Supplements breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Equine Pharmaceuticals and Supplements market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Equine Pharmaceuticals and Supplements sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Equine Pharmaceuticals and Supplements Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Equine Pharmaceuticals and Supplements Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Pharmaceuticals
1.2.3 Supplements
1.3 Market Analysis by Application
1.3.1 Overview: Global Equine Pharmaceuticals and Supplements Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Thoroughbred Horse
1.3.3 Other Types of Horses
1.4 Global Equine Pharmaceuticals and Supplements Market Size & Forecast
1.4.1 Global Equine Pharmaceuticals and Supplements Sales in Value (2016-2026))
1.4.2 Global Equine Pharmaceuticals and Supplements Sales in Volume (2016-2026)
1.4.3 Global Equine Pharmaceuticals and Supplements Price by Type (2016-2026) & (USD/Unit)
1.5 Global Equine Pharmaceuticals and Supplements Production Capacity Analysis
1.5.1 Global Equine Pharmaceuticals and Supplements Total Production Capacity (2016-2026)
1.5.2 Global Equine Pharmaceuticals and Supplements Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Equine Pharmaceuticals and Supplements Market Drivers
1.6.2 Equine Pharmaceuticals and Supplements Market Restraints
1.6.3 Equine Pharmaceuticals and Supplements Trends Analysis
2 Manufacturers Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product and Services
2.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Merck Animal Health
2.2.1 Merck Animal Health Details
2.2.2 Merck Animal Health Major Business
2.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Product and Services
2.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Zoetis
2.3.1 Zoetis Details
2.3.2 Zoetis Major Business
2.3.3 Zoetis Equine Pharmaceuticals and Supplements Product and Services
2.3.4 Zoetis Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Bayer Animal Health
2.4.1 Bayer Animal Health Details
2.4.2 Bayer Animal Health Major Business
2.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Product and Services
2.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Elanco Animal Health
2.5.1 Elanco Animal Health Details
2.5.2 Elanco Animal Health Major Business
2.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Product and Services
2.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Dechra Veterinary Products
2.6.1 Dechra Veterinary Products Details
2.6.2 Dechra Veterinary Products Major Business
2.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product and Services
2.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 CEVA
2.7.1 CEVA Details
2.7.2 CEVA Major Business
2.7.3 CEVA Equine Pharmaceuticals and Supplements Product and Services
2.7.4 CEVA Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Virbac
2.8.1 Virbac Details
2.8.2 Virbac Major Business
2.8.3 Virbac Equine Pharmaceuticals and Supplements Product and Services
2.8.4 Virbac Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Norbrook Equine
2.9.1 Norbrook Equine Details
2.9.2 Norbrook Equine Major Business
2.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Product and Services
2.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Kyoritsu Seiyaku
2.10.1 Kyoritsu Seiyaku Details
2.10.2 Kyoritsu Seiyaku Major Business
2.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product and Services
2.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Vetoquinol
2.11.1 Vetoquinol Details
2.11.2 Vetoquinol Major Business
2.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Product and Services
2.11.4 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Protexin Healthcare
2.12.1 Protexin Healthcare Details
2.12.2 Protexin Healthcare Major Business
2.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Product and Services
2.12.4 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Audevard
2.13.1 Audevard Details
2.13.2 Audevard Major Business
2.13.3 Audevard Equine Pharmaceuticals and Supplements Product and Services
2.13.4 Audevard Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Ouro Fino Saude
2.14.1 Ouro Fino Saude Details
2.14.2 Ouro Fino Saude Major Business
2.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product and Services
2.14.4 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Equine Pharmaceuticals and Supplements Sales by Manufacturer
3.1 Global Equine Pharmaceuticals and Supplements Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Equine Pharmaceuticals and Supplements Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Equine Pharmaceuticals and Supplements
3.4 Market Concentration Rate
3.4.1 Top 3 Equine Pharmaceuticals and Supplements Manufacturer Market Share
3.4.2 Top 6 Equine Pharmaceuticals and Supplements Manufacturer Market Share
3.5 Global Equine Pharmaceuticals and Supplements Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Equine Pharmaceuticals and Supplements Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Equine Pharmaceuticals and Supplements Market Size by Region
4.1.1 Global Equine Pharmaceuticals and Supplements Sales in Volume by Region (2016-2026)
4.1.2 Global Equine Pharmaceuticals and Supplements Revenue by Region (2016-2026)
4.2 North America Equine Pharmaceuticals and Supplements Revenue (2016-2026)
4.3 Europe Equine Pharmaceuticals and Supplements Revenue (2016-2026)
4.4 Asia-Pacific Equine Pharmaceuticals and Supplements Revenue (2016-2026)
4.5 South America Equine Pharmaceuticals and Supplements Revenue (2016-2026)
4.6 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Equine Pharmaceuticals and Supplements Sales in Volume by Type (2016-2026)
5.2 Global Equine Pharmaceuticals and Supplements Revenue by Type (2016-2026)
5.3 Global Equine Pharmaceuticals and Supplements Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Equine Pharmaceuticals and Supplements Sales in Volume by Application (2016-2026)
6.2 Global Equine Pharmaceuticals and Supplements Revenue by Application (2016-2026)
6.3 Global Equine Pharmaceuticals and Supplements Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Equine Pharmaceuticals and Supplements Sales by Type (2016-2026)
7.2 North America Equine Pharmaceuticals and Supplements Sales by Application (2016-2026)
7.3 North America Equine Pharmaceuticals and Supplements Market Size by Country
7.3.1 North America Equine Pharmaceuticals and Supplements Sales in Volume by Country (2016-2026)
7.3.2 North America Equine Pharmaceuticals and Supplements Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Equine Pharmaceuticals and Supplements Sales by Type (2016-2026)
8.2 Europe Equine Pharmaceuticals and Supplements Sales by Application (2016-2026)
8.3 Europe Equine Pharmaceuticals and Supplements Market Size by Country
8.3.1 Europe Equine Pharmaceuticals and Supplements Sales in Volume by Country (2016-2026)
8.3.2 Europe Equine Pharmaceuticals and Supplements Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Type (2016-2026)
9.2 Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Application (2016-2026)
9.3 Asia-Pacific Equine Pharmaceuticals and Supplements Market Size by Region
9.3.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Equine Pharmaceuticals and Supplements Sales by Type (2016-2026)
10.2 South America Equine Pharmaceuticals and Supplements Sales by Application (2016-2026)
10.3 South America Equine Pharmaceuticals and Supplements Market Size by Country
10.3.1 South America Equine Pharmaceuticals and Supplements Sales in Volume by Country (2016-2026)
10.3.2 South America Equine Pharmaceuticals and Supplements Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Type (2016-2026)
11.2 Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Application (2016-2026)
11.3 Middle East & Africa Equine Pharmaceuticals and Supplements Market Size by Country
11.3.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Equine Pharmaceuticals and Supplements Typical Distributors
12.3 Equine Pharmaceuticals and Supplements Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Equine Pharmaceuticals and Supplements Revenue by Type, (USD Million), 2021-2026
Table 2. Global Equine Pharmaceuticals and Supplements Revenue by Application, (USD Million), 2021-2026
Table 3. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 4. Boehringer Ingelheim Major Business
Table 5. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product and Services
Table 6. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 8. Merck Animal Health Major Business
Table 9. Merck Animal Health Equine Pharmaceuticals and Supplements Product and Services
Table 10. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Zoetis Basic Information, Manufacturing Base and Competitors
Table 12. Zoetis Major Business
Table 13. Zoetis Equine Pharmaceuticals and Supplements Product and Services
Table 14. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Bayer Animal Health Basic Information, Manufacturing Base and Competitors
Table 16. Bayer Animal Health Major Business
Table 17. Bayer Animal Health Equine Pharmaceuticals and Supplements Product and Services
Table 18. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Elanco Animal Health Basic Information, Manufacturing Base and Competitors
Table 20. Elanco Animal Health Major Business
Table 21. Elanco Animal Health Equine Pharmaceuticals and Supplements Product and Services
Table 22. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Dechra Veterinary Products Basic Information, Manufacturing Base and Competitors
Table 24. Dechra Veterinary Products Major Business
Table 25. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product and Services
Table 26. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. CEVA Basic Information, Manufacturing Base and Competitors
Table 28. CEVA Major Business
Table 29. CEVA Equine Pharmaceuticals and Supplements Product and Services
Table 30. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Virbac Basic Information, Manufacturing Base and Competitors
Table 32. Virbac Major Business
Table 33. Virbac Equine Pharmaceuticals and Supplements Product and Services
Table 34. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Norbrook Equine Basic Information, Manufacturing Base and Competitors
Table 36. Norbrook Equine Major Business
Table 37. Norbrook Equine Equine Pharmaceuticals and Supplements Product and Services
Table 38. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Kyoritsu Seiyaku Basic Information, Manufacturing Base and Competitors
Table 40. Kyoritsu Seiyaku Major Business
Table 41. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product and Services
Table 42. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Vetoquinol Basic Information, Manufacturing Base and Competitors
Table 44. Vetoquinol Major Business
Table 45. Vetoquinol Equine Pharmaceuticals and Supplements Product and Services
Table 46. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Protexin Healthcare Basic Information, Manufacturing Base and Competitors
Table 48. Protexin Healthcare Major Business
Table 49. Protexin Healthcare Equine Pharmaceuticals and Supplements Product and Services
Table 50. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Audevard Basic Information, Manufacturing Base and Competitors
Table 52. Audevard Major Business
Table 53. Audevard Equine Pharmaceuticals and Supplements Product and Services
Table 54. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Ouro Fino Saude Basic Information, Manufacturing Base and Competitors
Table 56. Ouro Fino Saude Major Business
Table 57. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product and Services
Table 58. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Global Equine Pharmaceuticals and Supplements Sales by Manufacturer (2019-2021e) & (K Units)
Table 60. Global Equine Pharmaceuticals and Supplements Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 61. Market Position of Manufacturers in Equine Pharmaceuticals and Supplements, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 62. Global Equine Pharmaceuticals and Supplements Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Equine Pharmaceuticals and Supplements Production Site of Key Manufacturer
Table 64. Equine Pharmaceuticals and Supplements New Entrant and Capacity Expansion Plans
Table 65. Equine Pharmaceuticals and Supplements Mergers & Acquisitions in the Past Five Years
Table 66. Global Equine Pharmaceuticals and Supplements Sales by Region (2016-2021e) & (K Units)
Table 67. Global Equine Pharmaceuticals and Supplements Sales by Region (2021-2026) & (K Units)
Table 68. Global Equine Pharmaceuticals and Supplements Revenue by Region (2016-2021e) & (USD Million)
Table 69. Global Equine Pharmaceuticals and Supplements Revenue by Region (2021-2026) & (USD Million)
Table 70. Global Equine Pharmaceuticals and Supplements Sales by Type (2016-2021e) & (K Units)
Table 71. Global Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units)
Table 72. Global Equine Pharmaceuticals and Supplements Revenue by Type (2016-2021e) & (USD Million)
Table 73. Global Equine Pharmaceuticals and Supplements Revenue by Type (2021-2026) & (USD Million)
Table 74. Global Equine Pharmaceuticals and Supplements Price by Type (2016-2021e) & (USD/Unit)
Table 75. Global Equine Pharmaceuticals and Supplements Price by Type (2021-2026) & (USD/Unit)
Table 76. Global Equine Pharmaceuticals and Supplements Sales by Application (2016-2021e) & (K Units)
Table 77. Global Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units)
Table 78. Global Equine Pharmaceuticals and Supplements Revenue by Application (2016-2021e) & (USD Million)
Table 79. Global Equine Pharmaceuticals and Supplements Revenue by Application (2021-2026) & (USD Million)
Table 80. Global Equine Pharmaceuticals and Supplements Price by Application (2016-2021e) & (USD/Unit)
Table 81. Global Equine Pharmaceuticals and Supplements Price by Application (2021-2026) & (USD/Unit)
Table 82. North America Equine Pharmaceuticals and Supplements Sales by Country (2016-2021e) & (K Units)
Table 83. North America Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units)
Table 84. North America Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021e) & (USD Million)
Table 85. North America Equine Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (USD Million)
Table 86. North America Equine Pharmaceuticals and Supplements Sales by Type (2016-2021e) & (K Units)
Table 87. North America Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units)
Table 88. North America Equine Pharmaceuticals and Supplements Sales by Application (2016-2021e) & (K Units)
Table 89. North America Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units)
Table 90. Europe Equine Pharmaceuticals and Supplements Sales by Country (2016-2021e) & (K Units)
Table 91. Europe Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units)
Table 92. Europe Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021e) & (USD Million)
Table 93. Europe Equine Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (USD Million)
Table 94. Europe Equine Pharmaceuticals and Supplements Sales by Type (2016-2021e) & (K Units)
Table 95. Europe Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units)
Table 96. Europe Equine Pharmaceuticals and Supplements Sales by Application (2016-2021e) & (K Units)
Table 97. Europe Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units)
Table 98. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Region (2016-2021e) & (K Units)
Table 99. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Region (2021-2026) & (K Units)
Table 100. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2016-2021e) & (USD Million)
Table 101. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2021-2026) & (USD Million)
Table 102. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Type (2016-2021e) & (K Units)
Table 103. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units)
Table 104. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Application (2016-2021e) & (K Units)
Table 105. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units)
Table 106. South America Equine Pharmaceuticals and Supplements Sales by Country (2016-2021e) & (K Units)
Table 107. South America Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units)
Table 108. South America Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021e) & (USD Million)
Table 109. South America Equine Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (USD Million)
Table 110. South America Equine Pharmaceuticals and Supplements Sales by Type (2016-2021e) & (K Units)
Table 111. South America Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units)
Table 112. South America Equine Pharmaceuticals and Supplements Sales by Application (2016-2021e) & (K Units)
Table 113. South America Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units)
Table 114. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Country (2016-2021e) & (K Units)
Table 115. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units)
Table 116. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021e) & (USD Million)
Table 117. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (USD Million)
Table 118. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Type (2016-2021e) & (K Units)
Table 119. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units)
Table 120. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Application (2016-2021e) & (K Units)
Table 121. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units)
Table 122. Direct Channel Pros & Cons
Table 123. Indirect Channel Pros & Cons
Table 124. Equine Pharmaceuticals and Supplements Typical Distributors
Table 125. Equine Pharmaceuticals and Supplements Typical Customers
List of Figures
Figure 1. Equine Pharmaceuticals and Supplements Picture
Figure 2. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type in 2020
Figure 3. Pharmaceuticals
Figure 4. Supplements
Figure 5. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2020
Figure 6. Thoroughbred Horse
Figure 7. Other Types of Horses
Figure 8. Global Equine Pharmaceuticals and Supplements Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Equine Pharmaceuticals and Supplements Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Equine Pharmaceuticals and Supplements Sales (2016-2026) & (K Units)
Figure 11. Global Equine Pharmaceuticals and Supplements Price by Type (2016-2026) & (USD/Unit)
Figure 12. Global Equine Pharmaceuticals and Supplements Production Capacity (2016-2026) & (K Units)
Figure 13. Global Equine Pharmaceuticals and Supplements Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Equine Pharmaceuticals and Supplements Market Drivers
Figure 15. Equine Pharmaceuticals and Supplements Market Restraints
Figure 16. Equine Pharmaceuticals and Supplements Market Trends
Figure 17. Global Equine Pharmaceuticals and Supplements Sales Market Share by Manufacturer in 2020
Figure 18. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Manufacturer in 2020
Figure 19. Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Equine Pharmaceuticals and Supplements Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Equine Pharmaceuticals and Supplements Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2016-2026)
Figure 23. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2016-2026)
Figure 24. North America Equine Pharmaceuticals and Supplements Revenue (2016-2026) & (USD Million)
Figure 25. Europe Equine Pharmaceuticals and Supplements Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue (2016-2026) & (USD Million)
Figure 27. South America Equine Pharmaceuticals and Supplements Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue (2016-2026) & (USD Million)
Figure 29. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2026)
Figure 30. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2016-2026)
Figure 31. Global Equine Pharmaceuticals and Supplements Price by Type (2016-2026) & (USD/Unit)
Figure 32. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2026)
Figure 33. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2016-2026)
Figure 34. Global Equine Pharmaceuticals and Supplements Price by Application (2016-2026) & (USD/Unit)
Figure 35. North America Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2026)
Figure 36. North America Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2026)
Figure 37. North America Equine Pharmaceuticals and Supplements Sales Market Share by Country (2016-2026)
Figure 38. North America Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2016-2026)
Figure 39. United States Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2026)
Figure 43. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2026)
Figure 44. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country (2016-2026)
Figure 45. Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2016-2026)
Figure 46. Germany Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2016-2026)
Figure 55. China Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2026)
Figure 62. South America Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2026)
Figure 63. South America Equine Pharmaceuticals and Supplements Sales Market Share by Country (2016-2026)
Figure 64. South America Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
